NCT05473195
- Conditions
- Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
- Locations
-
- TASK Clinical Research Centre Cape Town, Western Cape, South Africa
Clinical trial condition
Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
Explore clinical trials studying Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB). Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies